A client on a thiazide-type diuretic reports muscle cramps and weakness. Which laboratory abnormality is most consistent?

Thiazide diuretics such as hydrochlorothiazide act on the distal convoluted tubule to inhibit sodium-chloride reabsorption. As sodium is excreted, water follows, but potassium secretion is simultaneously enhanced because increased sodium delivery to the collecting duct stimulates aldosterone-mediated potassium excretion. The result is hypokalemia — low serum potassium — which manifests clinically as muscle cramps, weakness, and fatigue, exactly as described in this stem. Low potassium impairs normal neuromuscular transmission and reduces the resting membrane potential of muscle cells, leading to the cramping and weakness reported. High potassium (hyperkalemia) is associated with potassium-sparing diuretics such as spironolactone, not thiazides. Low calcium can also cause muscle cramping, but thiazides actually tend to reduce urinary calcium excretion and can mildly raise serum calcium — they are sometimes used to prevent calcium oxalate kidney stones for this reason. Low uric acid is not associated with thiazide use; in fact, thiazides compete with urate for renal tubular secretion and commonly raise uric acid levels, potentially precipitating gout. Therefore, hypokalemia is the laboratory finding that most consistently explains this patient's symptoms.